The WIN Consortium is a joint initiative of the Institut Gustave Roussy and the University of Texas M. D. Anderson Cancer Center, in association with other leading cancer care institutions around the World. The Consortium aims to build new strategic alliances in oncology, creating innovative drug development programs and accelerating clinical trials and validation of new drugs for personalized cancer care.


This major event, supported by media partner the Nature Publishing Group, will present breakthrough scientific technologies and achievements in personalized cancer medicine, with a special focus on individualized treatment and early diagnosis of cancer.

Organized by kdm communications & MF Congrès